{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:26:20Z","timestamp":1783664780447,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["6\/2562"],"award-info":[{"award-number":["6\/2562"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Thailand Science Research and Innovation Fund Chulalongkorn University","award":["CU_FRB65_hea (19)_026_30_07"],"award-info":[{"award-number":["CU_FRB65_hea (19)_026_30_07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The first case of <jats:italic>Taralomyces flavus<\/jats:italic> infection in human and peritoneal dialysis (PD) patient after exposure to biocontrol agent fumes is reported here.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 77-year-old Thai female farmer with kidney failure presented with peritonitis and PD catheter obstruction from fungal biofilms. The potential root cause of infection was associated with exposure to biocontrol-agent fumes containing pathogen during agricultural work in her garden. This source of infection has not been mentioned previously. Showering and changing clothes right after outdoor activity with a high density of fungal matters or dust should be added to the routine aseptic technique before performing PD bag exchange to prevent the system contamination. Although the patient received early treatment with liposomal amphotericin B, itraconazole, and catheter removal, according to the ISPD Guideline 2016 and the Global Guideline 2021, the outcome was unfavorable. Antifungal susceptibility testing later revealed that the pathogen was only susceptible to voriconazole. Thus, antifungal susceptibility should be tested if the patient fails or slowly responds to the primary antifungal regimen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>T. flavus<\/jats:italic> peritonitis is reported here after exposure to biocontrol-agent fumes containing the pathogen. This work also alerts and reiterates nephrology peers to be aware of this overlooked source of peritonitis, the exposure to dusty environments, specifically containing biocontrol-agent fumes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02898-1","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:03:19Z","timestamp":1660046599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Peritonitis after exposure to biocontrol-agent fumes containing Talaromyces flavus: a case report in peritoneal dialysis patient"],"prefix":"10.1186","volume":"23","author":[{"given":"Phanit","family":"Sookto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2996-8934","authenticated-orcid":false,"given":"Talerngsak","family":"Kanjanabuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamonwan","family":"Chamroensakchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisa","family":"Thongbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Eiam-Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"issue":"1","key":"2898_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3747\/pdi.2013.00179","volume":"35","author":"AC Nadeau-Fredette","year":"2015","unstructured":"Nadeau-Fredette AC, Bargman JM. Characteristics and outcomes of fungal peritonitis in a modern North American cohort. Perit Dial Int. 2015;35(1):78\u201384.","journal-title":"Perit Dial Int"},{"key":"2898_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","volume":"36","author":"PK Li","year":"2016","unstructured":"Li PK, Szeto CC, Piraino B, De AJ, Fan S, Figueiredo AE, et al. ISPD guidelines\/recommendations ISPD peritonitis recommendations\u202f: 2016 Update on prevention and treatment. Perit Dial Int. 2016;36:481\u2013508.","journal-title":"Perit Dial Int"},{"issue":"20","key":"2898_CR3","first-page":"30784","volume":"S1473\u20133099","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M, Salmanton-Garc\u00eda J, Walsh TJ, Nucci M, Neoh CF, Jenks JD, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis. 2021;S1473\u20133099(20):30784\u201392.","journal-title":"Lancet Infect Dis"},{"key":"2898_CR4","unstructured":"The European Committee on Antimicrobial Susceptibility Testing \u2013 EUCAST. Clinical breakpoints and dosing of antibiotics. https:\/\/www.eucast.org\/clinical_breakpoints\/ (Published 6 Jan 2021, accessed 1 Jun 2021)."},{"issue":"2","key":"2898_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","volume":"42","author":"PK Li","year":"2022","unstructured":"Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110\u201353.","journal-title":"Perit Dial Int"},{"key":"2898_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3747\/pdi.2014.00235","volume":"36","author":"A Leelahavanichkul","year":"2015","unstructured":"Leelahavanichkul A, Pongpirul K, Thongbor N, Worasilchai N, Petphuak K, Thongsawang B, et al. (1\u21923)-\u03b2-D-Glucan and galactomannan for a differentiation of chemical \u201cblack particles\u201d and fungal particles inside peritoneal dialysis tubing. Perit Dial Int. 2015;36:402\u20139.","journal-title":"Perit Dial Int"},{"key":"2898_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mmcr.2020.09.006","volume":"30","author":"T Thongsricome","year":"2020","unstructured":"Thongsricome T, Kanjanabuch T, Maeboonruen N, Pavatung P, Eiam-Ong S. Promising effect of in-situ lyticase enzyme therapy on peritoneal dialysis catheter obstruction from acremonium fungal biofilm: A case report. Med Myco Case Rep. 2020;30:26\u20138.","journal-title":"Med Myco Case Rep"},{"issue":"1","key":"2898_CR8","first-page":"37","volume":"40","author":"T Dethoup","year":"2007","unstructured":"Dethoup T, Manoch L, Visarathanonth N, Chamswarng CKA. Morphology and distribution of Talaromyces flavus from soil and potential use as a biological control agent against plant pathogenic fungi. Thai J Agric Sci. 2007;40(1):37\u201350.","journal-title":"Thai J Agric Sci"},{"issue":"1","key":"2898_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1139\/w01-130","volume":"48","author":"GD Inglis","year":"2002","unstructured":"Inglis GD, Kawchuk LM. Comparative degradation of oomycete, ascomycete, and basidiomycete cell walls by mycoparasitic and biocontrol fungi. Can J Microbiol. 2002;48(1):60\u201370.","journal-title":"Can J Microbiol"},{"key":"2898_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/089686080602600602","volume":"26","author":"J Bernardini","year":"2006","unstructured":"Bernardini J, Price V, Figueiredo A. ISPD guidelines\/recommendations peritoneal dialysis training. Perit Dial Int. 2006;26:625\u201332.","journal-title":"Perit Dial Int"},{"issue":"6","key":"2898_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3747\/pdi.2011.00057","volume":"31","author":"B Piraino","year":"2011","unstructured":"Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011;31(6):614\u201330.","journal-title":"Perit Dial Int"},{"key":"2898_CR12","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1111\/j.1440-1797.2004.00293.x","volume":"9","author":"Caring for Australians with Renal Impairment (CARI) Australasian guideline","year":"2004","unstructured":"Caring for Australians with Renal Impairment (CARI) Australasian guideline. The CARI guidelines: Evidence for peritonitis treatment and prophylaxis: treatment of peritoneal dialysis-associated fungal peritonitis. Nephrology (Carlton). 2004;9:S78-81.","journal-title":"Nephrology (Carlton)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02898-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:04:58Z","timestamp":1660046698000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02898-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2898"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02898-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chulalongkorn University does not require ethical approval for reporting individual cases or case series. Since the patient passed away, the patient\u2019s daughter provided written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient\u2019s daughter provided written informed consent to this case's publication. The consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.K. has received consultancy fees from VISTERRA as a country investigator and current recipient of the National Research Council of Thailand and received speaking honoraria from Astra Zeneca and Baxter Healthcare. All other authors declare that they have none.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}